Ignite Creation Date:
2024-05-05 @ 10:57 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01225965
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2010-10-20
Brief Title:
Efficacy and Feasibility of Ectoin Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung
Sponsor:
Bitop AG
Organization:
Bitop AG
Study Overview
Official Title:
An Efficacy and Feasibility Study to Investigate the Effect of Ectoin Inhalation Solution EIL in Subjects With Inflammation and Airway Obstruction Followed by a Long Term Study Extension on the Prevention of Lung Function Decline
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EFECT
Brief Summary:
To investigate the physical inflammation inhibition effects of EIL Ectoin-Hydro-Complex in subjects of the established SALIA-cohort and the preventive effects on lung function decline
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None